Protai has built an end-to-end AI-based platform that comprehensively maps the course of disease on the protein level, enhancing the ability to observe cellular function and improve the way new drugs are discovered.
| Website | http://protai.bio |
| Employees | 29 (16 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Proteomics, Ai Drug Discovery, Protein Analysis, Artificial Intelligence, Disease Modeling, Data Science, Cellular Function, Machine Learning, Ai Platform, Deep Learning, Drug Development, Genomics, Precision Medicine, Biomarker Discovery, Biotechnology, Therapeutic Targets, Pharmaceutical Research, Drug Design, Clinical Trials |
| Competitors | Amgen, Illumina, Moderna Therapeutics, Celerion, Twist Bioscience, bluebird bio, Editas Medicine, Zymergen, Inc., Asuragen, Synlogic +37 more (view full list) |
Looking for a particular Protai employee's phone or email?
Eran Seger is the CEO and Co-founder of Protai.
16 people are employed at Protai.